Boston-based Albireo Pharma Inc. said June 8 that Julia Brown and Heather Preston resigned from its board of directors.
Albireo added Anne Klibanski and Stephanie Okey to the board to fill the vacated positions.
Klibanski serves as chief academic officer for Partners HealthCare and as academic dean for Partners HealthCare at Harvard Medical School. Okey was most recently senior vice president, head of North America for rare diseases, and U.S. general manager for rare diseases at Sanofi unit Genzyme Corp.
Albireo develops therapies for orphan pediatric liver diseases and gastrointestinal disorders in the U.S.
